Genscript Biotech Corp (OTCPK:GNNSF)
$ 1.26 0 (0%) Market Cap: 2.94 Bil Enterprise Value: 1.51 Bil PE Ratio: 0 PB Ratio: 2.17 GF Score: 66/100

Half Year 2020 Genscript Biotech Corp Earnings Call Transcript

Aug 31, 2020 / 12:00AM GMT
Release Date Price: $2.02
Operator

Ladies and gentlemen, thank you for standing by. And welcome to the Genscript Biotech 2020 Interim Results Earnings Call. (Operator Instructions) Please be advised that today's conference is being recorded. I'd now like to hand the call over to your first speaker today, Mr. Shiniu Wei. Thank you. Please go ahead.

Shiniu Wei
Genscript Biotech Corporation - VP, Investor Relations

Thank you, Operator. Good morning everyone. Welcome to Genscript 2020 1st Half Results Conference. My name is Shiniu Wei, VP of Investor Relations at Genscript.

We also have the following management team attending today's call: Dr. Frank Zhang, Chairman of the Board for Genscript and CEO of Legend Biotech; Dr. Patrick Liu, Rotating CEO of Genscript; Dr. Brian Min, CEO of Genscript Probio; Mr. Aaron Qian, VP of Finance at Genscript.

Before we begin today, I'd like to remind everyone that today's call, we will be making statements about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts which may

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot